CompletedNCT00844753
Atomoxetine with or without parent training for autistic children with ADHD
About this title
Read the official source — NCT00844753Medication studyAges 5–14United States
Understand this study
Who was this study for?
Listed age limits: 5 years to 14 years.
- Listed locations
- Rochester and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 128
- Sponsor
- University of Rochester
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 5 Years to 14 Years
- Official registry ID
- NCT00844753
- Official title
Show the full official title
Atomoxetine, Placebo and Parent Management Training in Autism
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Rochester · Columbus · Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Rochester, a university.
Did this study involve medication?
Yes. The study involved medication, including atomoxetine and Placebo.
Who was this study for?
Listed age limits: 5 years to 14 years.
